Business Intelligence

Ping An Insurance Company of China’s corporate venture fund is investing in AI medical solution company Airdoc, the company announced on Saturday, Jan. 12.

Two-thirds of public citizens in the Middle East are ready to embrace AI in healthcare, while only 10 percent of businesses in the region are ready or have begun adopting the technology, according to a new report by PwC Middle East.

More than 75 percent of healthcare executive leaders said their organization is increasing the pace of investment in big data and AI, with a majority citing fear of disruption by competitors, according to a survey by NewVantage Partners.

Verily, a subsidiary of Google parent company Alphabet, raised $1 billion in investment funding to support growth in strategic partnership investments, global business development opportunities and potential acquisitions, the company announced Jan. 3.

Amid widespread concerns about hacking threats and privacy, HHS and industry leaders released voluntary cybersecurity practices to help protect healthcare organizations from threats and keep patient information safe.

The AI in healthcare market is expected to grow from $2.1 billion in 2018 to $36.1 billion by 2025, according to a report by Markets and Markets.

The newly-formed Alliance for Artificial Intelligence in Healthcare will officially launch this month, with its first board meeting set for Jan. 9 in San Francisco.

Here are AI in Healthcare’s top 10 AI and clinical innovation stories from 2018.

John Giannandrea has been named Apple’s senior vice president of machine learning and AI strategy, the company announced Thursday.

Minnesota-based multinational conglomerate 3M has acquired speech recognition software developer M*Modal for $1 billion, according to a report by the Pittsburgh Post-Gazette. M*Modal provides healthcare technology and conversational AI-powered systems for transcribing doctors’ verbal notes.

Though the use of deep-learning techniques has the potential to change several areas of medicine, the technology faces numerous challenges before it can be applied more broadly, according to a viewpoint article published in JAMA Internal Medicine.

AI and big data to have the “greatest technology impact” in the pharmaceutical industry in 2019, according to a recent report by GlobalData.